Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Osimertinib","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=osimertinib","facts":[{"label":"Active ingredient \/ generic name","value":"osimertinib"}]},{"title":"Tegretol 200 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=tegretol-200-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Karbamazepin"},{"label":"ATC code","value":"N03AF01"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed TAGRISSO SPL v37, effective 2026-09-14; checked 2026-11-04; 7.1"}],"sources":[{"label":"TAGRISSO (osimertinib) \u2014 US prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:36171","available":true}}